author-photo

Katherine Riester

Biogen Idec

37

Papers

883

Citations

Citation Trend

Filter By

Papers (29) Sort By

Journal Conference Others

Next-generation Bruton's tyrosine kinase inhibitor BIIB091 selectively and potently inhibits B cell and Fc receptor signaling and downstream functions in B cells and myeloid cells.

2021 Clinical And Translational Immunology
Show All
- Source
- Cite
- Save
Citations (2)
Effect of dimethyl fumarate on lymphocyte subsets in patients with relapsing multiple sclerosis.

2020
Show All
- Source
- Cite
- Save
Citations (3)
Comparative effectiveness of dimethyl fumarate versus fingolimod and teriflunomide among MS patients switching from first-generation platform therapies in the US

2019 Multiple sclerosis and related disorders
Show All
- Source
- Cite
- Save
Citations (29)
Impact of informative censoring on the treatment effect estimate of disability worsening in multiple sclerosis clinical trials

2019 Multiple sclerosis and related disorders
Show All
- Source
- Cite
- Save
Citations (2)
Effect of Bismuth Subsalicylate on Gastrointestinal Tolerability in Healthy Volunteers Receiving Oral Delayed-release Dimethyl Fumarate: PREVENT, a Randomized, Multicenter, Double-blind, Placebo-controlled Study

2018 Clinical Therapeutics
Show All
- Source
- Cite
- Save
Citations (6)
Improved cognitive outcomes in patients with relapsing–remitting multiple sclerosis treated with daclizumab beta: Results from the DECIDE study:

2018 Multiple Sclerosis Journal
Show All
- Source
- Cite
- Save
Citations (27)
Cells during CD25 Blockade In Vivo Maintenance of Human Regulatory T

2017
Show All
- Source
- Cite
- Save
Citations (0)
Impact of daclizumab versus interferon beta-1a on patient-reported outcomes in relapsing-remitting multiple sclerosis

2017 Multiple sclerosis and related disorders
Show All
- Source
- Cite
- Save
Citations (8)
COMPARATIVE EFFECTIVENESS OF DELAYED-RELEASE DIMETHYL FUMARATE VERSUS FINGOLIMOD AND TERIFLUNOMIDE ON RISK OF RELAPSE (P6.375)

2017 Neurology
Show All
- Source
- Cite
- Save
Citations (2)
Reversible Effects of Daclizumab HYP on Lymphocyte Counts in RRMS Patients: Data from the SELECT Trilogy Studies (P5.281)

2016 Neurology
Show All
- Source
- Cite
- Save
Citations (1)